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Fowl adenoviruses (FAdV) are members of the genus Aviadenovirus, family Adenoviridae, and currently comprise subgroups I, II, and III. In contrast with the clear association of subgroup II and subgroup III FAdV with disease, the role of most subgroup I FAdV as pathogens is not well defined ([@B1]). Subgroup I FAdV can be subdivided into five genotypes (A to E) and 12 serotypes (FAdV-1 to FAdV-8a and FAdV-8b to FAdV-11) ([@B2], [@B3]). FAdV-1, FAdV-2, FAdV-8a, FAdV-8b, and FAdV-11 can cause inclusion body hepatitis ([@B4], [@B5]), and FAdV-4 can result in hydropericardium syndrome ([@B6]).

We collected livers from chickens with mild respiratory symptoms in Jiangsu Province of China, and liver homogenate was inoculated into 9-day-old specific-pathogen-free (SPF) chicken eggs via the chorioallantoic membrane. Virus JS2017 was further propagated on a chicken liver cancer cell line (LMH) for 72 h. Viral double-stranded DNA (dsDNA) was extracted from cell culture using the phenol-chloroform method. The hexon (including the loop 1 \[L1\] hexon region) was amplified and sequenced using Sanger sequencing to identify the group and type of FAdV ([@B7]). The BLAST search results showed that the isolate had 98.25% to 99.23% similarity to other FAdV-1 strains. To better understand the genetic characteristics of FAdV-1, the nearly complete genome sequence of strain JS2017 was amplified by PCR using 34 overlapping pairs of primers ([Table 1](#tab1){ref-type="table"}). All PCRs were performed according the instructions for *TransTaq* HiFi DNA polymerase (TransGen Biotech). The 34 overlapping PCR products were cloned and Sanger sequenced (General Biosystems, Anhui, China). Each base was covered by three individual Sanger reads. Vector sequences were removed by the EditSeq program (Lasergene 8.0), and the full-length sequence was assembled using SeqMan (Lasergene 8.0). The nearly complete genome of JS2017 is 43,681 nucleotides (nt) long, with a 54.29% G+C content. Thirty-four open reading frames (ORFs) were predicted within the genome using the ORFfinder tool (<https://www.ncbi.nlm.nih.gov/orffinder/>), and the inverted terminal repeat (ITR) sequences are 54 nt long. A comparison of the nucleotide identity of JS2017 with four FAdV-1 reference strains, CELO (GenBank accession no. [U46933](https://www.ncbi.nlm.nih.gov/nuccore/U46933)), W-15 ([KX247011](https://www.ncbi.nlm.nih.gov/nuccore/KX247011)), 61/11z ([KX247012](https://www.ncbi.nlm.nih.gov/nuccore/KX247012)), and JM1-1 ([MF168407](https://www.ncbi.nlm.nih.gov/nuccore/MF168407)), showed similarities of 99.3%, 99.6%, 99.7%, and 99.3%, respectively. The JS2017 strain possessed multiple insertions and deletions compared to reference FAdV-1 strain CELO, including in ORF8, ORF14, and the IVa2 and L4 100K genes. Amino acid comparison showed that the major hexon capsid protein of JS2017 has high similarity, ranging between 99.6% and 100%, with those of these four FAdV-1 strains. Furthermore, compared with those of reference strain CELO, the penton and fiber-2 of JS2017 have four and six amino acid mutations, respectively.

###### 

Primers used to amplify the complete genomic sequence of FAdV-1 strain JS2017

  Nucleotide position   Primer name                     Sequence (5′→3′)
  --------------------- ------------------------------- -------------------------------
  18587-19377           Hex-F1                          GAYRGYHGGRTNBTGGAYATGGG
  Hex-R1                TACTTATCNACRGCYTGRTTCCA         
  1--1414               FAdV-1-1-F                      GATGATGTATAATAACCTCAAAAACTAAC
  FAdV-1-1-R            CAGACAATGTCCGTATGTGTCG          
  1329--2784            FAdV-1-2-F                      GATAGGACCCTTGCGACGA
  FAdV-1-2-R            CTCCACGCCACAAACTGTTT            
  2623--4139            FAdV-1-3-F                      CAGCCAGGCGGATATTTGTA
  FAdV-1-3-R            CATCAGATGATGGAAGCCGA            
  4020--5444            FAdV-1-4-F                      CTTGGCGTTGGAAAGTCTTC
  FAdV-1-4-R            CCCCAAACTAACCGATCTCG            
  5360--6792            FAdV-1-5-F                      CGGTTCCTGAGTCTCTTAACG
  FAdV-1-5-R            CATTCACAACGAGCAGCTCA            
  6689--8171            FAdV-1-6-F                      GATTTGGGTGCTCATTGTCG
  FAdV-1-6-R            GAAATGTTAGACCCACTCCCTC          
  8066--9512            FAdV-1-7-F                      TGAGGATATCTATGACGGTGACC
  FAdV-1-7-R            GACGAAGGCTTCTATTGGCTA           
  9402--10786           FAdV-1-8-F                      GTAGCGGTCGACTAGATTTTGG
  FAdV-1-8-R            CCGAACATATCGCCTCTACAC           
  10625--12018          FAdV-1-9-F                      GTTGGATTGCTCGCTCCATA
  FAdV-1-9-R            CCGTTTAATGCAACTCCGAG            
  11879--13343          FAdV-1-10-F                     GGTTGTCGAAAAGGTAATCGTT
  FAdV-1-10-R           CAGATGAAGTCATCCTCGTCG           
  13168--14591          FAdV-1-11-F                     GTGTATAACAACCGACCAGCTC
  FAdV-1-11-R           CATCGAAATACTCGTCTCTGGA          
  14501--16016          FAdV-1-12-F                     GGTAATTACGTGATACCCGACC
  FAdV-1-12-R           CACGTTCCCTCCTTGAAGATC           
  15976--17000          FAdV-1-13-F                     GGTTTACGATTACGAAGATCT
  FAdV-1-13-R           GTCAAAAGAACGGAAGGCATA           
  16927--17951          FAdV-1-14-F                     TGAGATGTTCTTCTGACTATGTGTG
  FAdV-1-14-R           TGAATGAGAGCCTGCAGTTC            
  17860--18773          FAdV-1-15-F                     TTGAAGTTGCAACAGGATCTGG
  FAdV-1-15-R           ACACGTTGGTCATCTGTCCCA           
  18674--20090          FAdV-1-16-F                     ACGGCTTATAATCCCCTTGC
  FAdV-1-16-R           TATTGTGGTCCATGGGCATG            
  19982--21415          FAdV-1-17-F                     AACATGATTCTGCAGTCCAGC
  FAdV-1-17-R           TACTTGACTCTGTATAACTCCCACAG      
  21354--22784          FAdV-1-18-F                     TACATGTTTGACCCTTTCGGG
  FAdV-1-18-R           TTCCTGGCAGCCGTTATCTA            
  22651--24033          FAdV-1-19-F                     ATGTCCACACCGTGCATGC
  FAdV-1-19-R           TTCTGAGCTTCGCTTTCATCG           
  23949--25391          FAdV-1-20-F                     AACCTTCCGAAATGGACCG
  FAdV-1-20-R           ACATACCCATAGCCGTTTGC            
  25281--26816          FAdV-1-21-F                     TGAACAACTGCATCATGTCCAA
  FAdV-1-21-R           AGCATAGTAGCCTATGACAGTAGCG       
  26672--28138          FAdV-1-22-F                     AGGTAAATATCGCAGCTGGG
  FAdV-1-22-R           GTTCATGATGTCGAACCCTAGAA         
  28038--29537          FAdV-1-23-F                     TCAGCCAGAATACAAAACCG
  FAdV-1-23-R           TCAAGGGTTCCATCGTGTTT            
  29444--30916          FAdV-1-24-F                     CTTACAGTCACGAGTAACTCTCTCG
  FAdV-1-24-R           TCAACGACCAGGGTTTTGG             
  30763--32230          FAdV-1-25-F                     AATCTAACGGCAACGCGAT
  FAdV-1-25-R           GTTACCTTTGCATCGTATGGG           
  32076--33450          FAdV-1-26-F                     CTGGAGAGAAATCGCTAAACC
  FAdV-1-26-R           ATGAAGTACGACTTGGAACCG           
  33342--34827          FAdV-1-27-F                     GGAGAGCCATCTTTACGGATAT
  FAdV-1-27-R           AGGCTCCCATTGTTTTATATGC          
  34711--36190          FAdV-1-28-F                     TCACTTCCTGTGTCGTCATTG
  FAdV-1-28-R           AAGCTCGGAAATGGAGGC              
  36083--37560          FAdV-1-29-F                     ATCCCATCTGGAATCCGAC
  FAdV-1-29-R           TCGTAGTCTGCGAAGATTGC            
  37424--38907          FAdV-1-30-F                     AATCCCACCACTAGCCTTAGAG
  FAdV-1-30-R           TCTACCACCACGGGAAAGTC            
  38808--40311          FAdV-1-31-F                     GCCACAATGTAATTACCCACTG
  FAdV-1-31-R           GATGGTTAATGCCTTGTGACG           
  40224--41696          FAdV-1-32-F                     CTGGATACGGCAAACAATACC
  FAdV-1-32-R           TGGCAATTGTTCTAGAAATAGTTTT       
  41571--42798          FAdV-1-33-F                     GGATTTTCCAATGCGTCATT
  FAdV-1-33-R           AGAATGTTCCGAGAAGCTTTTC          
  42551--43739          FAdV-1-34-F                     TAAGTATGGACACCGCCGA
  FAdV-1-34-R           GATGATGTATAATAACCTCAAAAACTAAC   

Since JS2017 is nonpathogenic, it may provide an effective viral vector for future poultry vaccine research.
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The nearly complete genome sequence of serotype 1 fowl adenovirus strain JS2017 has been deposited in GenBank under accession no. [MK050972](https://www.ncbi.nlm.nih.gov/nuccore/MK050972).
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